![Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu](https://image.isu.pub/220523125456-31254084c0fc681ef531a9580454bbd7/jpg/page_1.jpg)
Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β- thalassemia | Haematologica
Sirolimus for Treatment of β-Thalassemia: From Pre-Clinical Studies to the Design of Clinical Trials
![Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine | Scientific Reports Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-00169-x/MediaObjects/41598_2021_169_Fig1_HTML.png)
Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine | Scientific Reports
![2021 update on clinical trials in β‐thalassemia - Musallam - 2021 - American Journal of Hematology - Wiley Online Library 2021 update on clinical trials in β‐thalassemia - Musallam - 2021 - American Journal of Hematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/caf537f7-2fd6-410b-9f9e-4bd2bf79cd29/ajh26316-fig-0001-m.jpg)
2021 update on clinical trials in β‐thalassemia - Musallam - 2021 - American Journal of Hematology - Wiley Online Library
![Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia](https://www.mdpi.com/biomolecules/biomolecules-11-00755/article_deploy/html/images/biomolecules-11-00755-g001.png)
Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia
![IJMS | Free Full-Text | Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management IJMS | Free Full-Text | Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management](https://www.mdpi.com/ijms/ijms-19-00182/article_deploy/html/images/ijms-19-00182-g001.png)
IJMS | Free Full-Text | Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
![A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies? - ScienceDirect A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0268960X17301303-gr1.jpg)
A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies? - ScienceDirect
![An urgent need for improving thalassemia care due to the wide gap in current real-life practice and clinical practice guidelines | Scientific Reports An urgent need for improving thalassemia care due to the wide gap in current real-life practice and clinical practice guidelines | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-92715-w/MediaObjects/41598_2021_92715_Fig1_HTML.png)